Can sequences be presented in drawing figures of a patent application?
Yes, sequences can be presented in drawing figures of a patent application, but there are specific guidelines to follow: According to 37 CFR 1.83(a), sequences included in sequence listings should not be duplicated in the drawings. However, the MPEP recognizes that “many significant sequence characteristics may only be demonstrated by a figure.” Examples of such…
Read MoreHow should sequence identifiers be presented in drawing figures?
According to MPEP 2422.02, sequence identifiers in drawing figures should be presented as follows: The sequence identifier must be included in the drawing where the sequence is presented. The sequence identifier should appear next to the sequence, preferably within the figure. The identifier should be placed in parentheses. Example format: (SEQ ID NO: X) The…
Read MoreWhy are drawing figures recommended for certain sequence representations?
Drawing figures are recommended for certain sequence representations because they can effectively illustrate important characteristics that may not be adequately conveyed in a standard sequence listing. The MPEP 2422.02 provides several reasons for this: Double-stranded nucleotides: “The representation of double stranded nucleotides is not permitted in the ‘Sequence Listing’.” Specific nucleotide features: “Many significant nucleotide…
Read MoreWhat happens if a sequence in a drawing is not included in the sequence listing?
If a sequence presented in a drawing is not included in the sequence listing, it can lead to compliance issues with the patent application. According to MPEP 2422.02: “If a sequence is presented in a drawing, the sequence must still be included in the sequence listing if the sequence falls within the definition set forth…
Read More